Brokerages Set Omada Health, Inc. (NASDAQ:OMDA) Price Target at $26.50

Posted by on Sep 7th, 2026

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) has been given a consensus rating of “Moderate Buy” by the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $26.50.

A number of equities research analysts have recently issued reports on OMDA shares. BTIG Research boosted their price target on shares of Omada Health from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Morgan Stanley reaffirmed an “overweight” rating and set a $30.00 price objective on shares of Omada Health in a research report on Monday, June 22nd. Barclays boosted their target price on Omada Health from $20.00 to $25.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. JPMorgan Chase & Co. upped their price target on Omada Health from $26.00 to $30.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Finally, Robert W. Baird raised their price target on Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 12th.

View Our Latest Report on OMDA

Insider Transactions at Omada Health

In related news, CFO Steven Cook sold 33,000 shares of the firm’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $19.89, for a total transaction of $656,370.00. Following the completion of the transaction, the chief financial officer directly owned 133,359 shares in the company, valued at $2,652,510.51. This trade represents a 19.84% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Sean Duffy sold 25,886 shares of Omada Health stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $22.68, for a total value of $587,094.48. Following the completion of the transaction, the chief executive officer directly owned 411,861 shares of the company’s stock, valued at approximately $9,341,007.48. This represents a 5.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 277,406 shares of company stock valued at $5,907,726 over the last 90 days. 6.38% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Omada Health

Several large investors have recently added to or reduced their stakes in OMDA. Quarry LP acquired a new stake in Omada Health during the 4th quarter worth approximately $29,000. Raymond James Financial Inc. purchased a new stake in shares of Omada Health during the second quarter worth $32,000. Versant Capital Management Inc raised its stake in shares of Omada Health by 319.3% in the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after acquiring an additional 2,283 shares in the last quarter. Strs Ohio raised its stake in shares of Omada Health by 151.0% in the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock valued at $67,000 after acquiring an additional 2,567 shares in the last quarter. Finally, New York State Common Retirement Fund purchased a new position in Omada Health in the fourth quarter valued at $73,000.

Omada Health Stock Performance

Shares of NASDAQ:OMDA opened at $22.77 on Monday. The company has a market capitalization of $1.39 billion, a price-to-earnings ratio of 455.40 and a beta of 1.86. Omada Health has a 12-month low of $10.28 and a 12-month high of $26.92. The business has a 50-day moving average price of $22.70 and a 200 day moving average price of $17.62.

Omada Health (NASDAQ:OMDA – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. The company had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. As a group, equities research analysts predict that Omada Health will post 0.09 earnings per share for the current fiscal year.

Omada Health Company Profile

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Featured Stories

Analyst Recommendations for Omada Health (NASDAQ:OMDA)

Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.